
NEW Guidance from UK’s NICE Diagnostic Assessment Programme (DAP) for Cryptogenic Stroke.
online
Tuesday 13th October 2020
5:00pm - 6:00pm
The UK’s National Institute for Health and Care Excellence (NICE) has assessed the clinical and economic effectiveness of ICMs in cryptogenic stroke patients and has published a Diagnostic Guidance on implantable cardiac monitors (ICMs) on September 2; 2020. A rigorous clinical and economic analysis shows Reveal LINQ Insertable cardiac monitor (ICM) as the only ICM recommended for patients following a cryptogenic stroke or TIA after external monitoring has been done and a cardiac arrhythmic cause of stroke is suspected. This live webinar will discuss implications for international healthcare systems and healthcare providers based on the NICE recommendations. Key opinion leaders in the field of stroke care will share their perspective on the new Diagnostic Guidance and explaining how these recommendations should guide use of ICMs in the treatment of stroke patients.
Thank you for you enquiry.
Your CPD request has been sent to the relevant accredited CPD provider. We hope this is of help.
Click here to search for more CPD courses and events.
Kind regards
The CPD Service